Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.

International guidelines recommend surgical revascularisation for unprotected left main (ULM) coronary artery disease. The introduction of drug-eluting stents (DES) as an emergency therapy has resulted in increasing numbers of patients having stents placed in ULM. As a consequence, important data on...

Detaylı Bibliyografya
Asıl Yazarlar:	De Caterina, A, Cuculi, F, Banning, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Yazar:: Porto, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
Yazar:: Chengbin Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
Yazar:: Schrale, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
Yazar:: Mohammad Saifur Rohman, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
Yazar:: Blackman, D, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
Yazar:: Nisha Ohri, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Yazar:: Violeta Dinesch, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
Yazar:: Blackman, D, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
Yazar:: Stone, GW, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Paclitaxel eluting stents versus bare metal stents restenosis
Yazar:: Ronald Aroche Aportela, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
Yazar:: Omar A. Meelu, MS, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
Yazar:: Negar Faramarzi, ve diğerleri
Baskı/Yayın Bilgisi: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
Yazar:: Sohila Refahi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
Yazar:: Jianbing Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
Yazar:: Birong Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Risk assessment score for drug eluting stent restenosis
Yazar:: Z. A. Gabbasov, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

In Stent Restenosis Predictors after Carotid Artery Stenting
Yazar:: Mirco Cosottini, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

CHADS-Vasc score and CHADS-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
Yazar:: Sheng Gang Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
Yazar:: N. G. Veselovskaya, ve diğerleri
Baskı/Yayın Bilgisi: (2014-09-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
Yazar:: Juan Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
Yazar:: Jorge A Arroyave C, ve diğerleri
Baskı/Yayın Bilgisi: (2012-06-01)

Hypersensitivity and in-stent restenosis in coronary stent materials
Yazar:: Wansong Hu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Stents versus bypass grafting for left main coronary artery disease.
Yazar:: Arnold, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
Yazar:: Abizaid, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
Yazar:: Mohamed Aboel-Kassem F. Abdelmegid, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

Axial deformation during coronary stenting: an extreme case.
Yazar:: De Caterina, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
Yazar:: Guillaume Marquis-Gravel, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
Yazar:: Xiao-Zeng Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
Yazar:: Kakhaber Etsadashvili, ve diğerleri
Baskı/Yayın Bilgisi: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
Yazar:: Yen-Wen Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Comparison of Gensini score and SYNTAX score for predicting in-stent restenosis in patients with coronary artery disease and drug-eluting stent implantation
Yazar:: Min-Tao Gai, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
Yazar:: Yasser Gaber Metwally, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
Yazar:: Wenjie Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
Yazar:: Hongfei Xi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Association of G22A variant of Adenosine Deaminase gene with coronary in-stent restenosis in coronary artery patients receiving drug-eluting stent
Yazar:: Elaheh Moosavi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
Yazar:: Yong Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
Yazar:: Kyle Murnaghan, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
Yazar:: Alain Guidon, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Yazar:: Ganesh Paramasivam, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
Yazar:: Luo Y, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)